EGFR and KRAS mutations during anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer: Clinically relevant?
Lucie Karayan-Tapon
No relevant relationships to disclose
Aurelie Ferru
No relevant relationships to disclose
Ulrich Cortes
No relevant relationships to disclose
Claire Villalva
No relevant relationships to disclose
Jean Marc Tourani
No relevant relationships to disclose
Christine Silvain
No relevant relationships to disclose
Pierre Levillain
No relevant relationships to disclose
David Tougeron
No relevant relationships to disclose